Aug 9, 2010
AstraZeneca to Pay $198 Million to Settle Seroquel Suits
London-based AstraZeneca PLC said Monday it has reached agreements to pay $198 million to settle a little more than half of the U.S. lawsuits that allege its antipsychotic drug Seroquel caused diabetes and other harm. AstraZeneca said the agreements cover roughly 17,500 claimants, out of the remaining 26,100 plaintiffs who have brought product liability lawsuits.